• Non ci sono risultati.

Scarica il programma in formato PDF

N/A
N/A
Protected

Academic year: 2022

Condividi "Scarica il programma in formato PDF"

Copied!
12
0
0

Testo completo

(1)

Advances

in Gynecologic Oncology

Advances

in Gynecologic Oncology

Advances

in Gynecologic Oncology

Advances

in Gynecologic Oncology

Milano 2 2 -2 3 giugno 2017 XXIX

Congresso Nazionale

Advances

in Gynecologic Oncology

Advances

in Gynecologic Oncology

Istituto Nazionale dei Tumori Aula Magna

Milan , 2 2 - 2 3 June 2017 XXVIII

Congresso Nazionale

w w w . a d v a n c e s g y n e c o l o g i c o n c o l o g y . o r g

(2)

DEAR COLLEAGUES

On behalf of the Executive Committee of the European Society of Gyneco- logic Oncology (ESGO) and the Italian Society of Gynecologic Oncology (SIOG), it is my pleasure and pride to invite you to the 3rd Advances in Gyne- cologic Oncology, that will be held in Milan on 22nd – 23rd June 2017.

Our meeting can be considered one of the major event in developing, upgrading and teaching the Gynecologic Oncology. The third edition of Advances in Gynecologic Oncology covers the most challenging areas of basic science and clinical applications in gynecologic oncology. The aim of the meeting is to collect experts in the field of gynecologic oncology.

The meeting covers diagnosis, biology and therapy of gynecological can- cers, thus highlighting issues and controversies in their management.

The Scientific program, developed by the Executive Board, will recei- ve contributions from Scientific Societies, mostly members of the Eu- ropean Society of Gynecologic Oncology (ESGO) the Italian Society of Gynecologic Oncology (SIOG) and the Multicenter Italian Trials in Ova- rian cancer (MITO) group, that cooperates with us. The XXVIII National Conference of the Italian Society of Gynecologic Oncology (SIOG) will take place during the course.

Hope to see you in Milan

Francesco Raspagliesi, M.D.

(3)

Advances

in Gynecologic Oncology

Advances

in Gynecologic Oncology

Advances

in Gynecologic Oncology

Advances

in Gynecologic Oncology

Milano 2 2 -2 3 giugno 2017 XXIX

Congresso Nazionale

FACULTY

Ghezzi Fabio

Giorda Giorgio (TBC)

Greggi Stefano

Grignani Giovanni

Guinot Jose Luis (TBC)

Katsaros Dionyssios

Laffranchi Alberto

Landoni Fabio

Lorusso Domenica

Maggino Tiziano

Mangili Giorgia

Mansoor Mirza Raza

Marchetti Claudia Martinelli Fabio Mascheroni Annalisa Mezzanzanica Delia Oaknin Ana Palaia Innocenza

Pecorelli Sergio

Perrone Franco

Pignata Sandro

Pujade Lauraine Eric Raspagliesi Francesco Ray Coquard Isabelle Rossi Elio

Salerno Maria Giovanna

Sartori Enrico

Scambia Giovanni

Scollo Paolo

Sehouli Jalid

Signorelli Mauro

Somigliana Edgardo

Vizza Enrico

Zamagni Claudio

Zola Paolo (TBC)

Zullo Fulvio

President

Francesco Raspagliesi Chief Department

of Ginecologic Oncology, IRCCS Istituto Nazionale dei Tumori di Milano

Organizing Committee Domenica Lorusso Department of Ginecologic Oncology,

IRCCS Istituto Nazionale dei Tumori di Milano

Speakers and Chairmen

Aletti Giovanni

Angioli Roberto

Biglia Nicoletta

Bocciolone Luca

Bogani Giorgio

Buda Alessandro

Casali Paolo

Cerrotta Anna Maria

Colombo Nicoletta

Cormio Nino

De Iaco Pierandrea

Ditto Antonino

Du Bois Andreas

Fagotti Anna

Ferrandina Maria Gabriella

Franchi Massimo

Gadducci Angiolo

(4)

CME CREDITS

The congress will be accredited for the following categories:

· PHYSICIANS

(Gynecology, Oncology, Radiotherapy, Pathological Anatomy, General Surgery, Genetics, Radiodiagnostics, Clinical Biochemistry, Endocrinology, Internal Medicine)

· NURSES and RADIATION THERAPISTS The CME credits will be awarded to the participants that will fulfill all the obligations under

the program of Continuing Medical Education

OFFICIAL LANGUAGE

The official language of the conference are English and Italian.

ENDORSEMENTS

(5)

THURSDAY JUNE 22nd, 2017

9:00 – 9:05 Welcome Francesco Raspagliesi 9:05 – 9:25 MAGISTRAL LECTURES

Independent research in Italy with the new European decree

Franco Perrone

9:25 – 9: 45 Sustainability of cancer treatment in the coming years Sergio Pecorelli

9:45–10:15 COFFEE BREAK

Pro & Cons in Gynecologic Oncology Session – “Early” Stage Ovarian Cancer

Chairmen: Massimo Franchi – Nicoletta Biglia – Nino Cormio 10:15 –10:55 Incomplete surgery

• Surgery pro Luca Bocciolone

• Chemo pro Angiolo Gadducci

• Take Home Messages Enrico Sartori

10:55 – 11:40 Fertility sparing treatment and patient selection:

• the surgeon point of view Antonino Ditto

• the oncologist point of view Giorgia Mangili

• the reproductive medicine specialist point of view Edgardo Somigliana

11:40 – 11:55 Translational research and Perspective Delia Mezzanzanica

11:55–12:05 Discussion

(6)

THURSDAY JUNE 22nd, 2017

Session – Ovarian Cancer – Stage III-IV treatment in 2017 Chairmen: Francesco Raspagliesi – Claudio Zamagni – Paolo Scollo 12:05 –12:25 Operability decision and surgical goals of

cytoreductive surgery Andreas Du Bois

12:25 –12:50 Primary surgery vs NACT : role of laparoscopy Giovanni Scambia

Take Home Messages Francesco Raspagliesi

12:50 –13•05 Frailty and Surgical Complexity score in the decision making process

Giovanni Aletti

13:05 – 14:05 LUNCH

Session – Ovarian Cancer – Hot Topics in Surgical Treatment Chairmen: Francesco Raspagliesi – Claudio Zamagni – Paolo Scollo 14:05 – 14:20 Secondary Cytoreduction is the new standard?

Andreas Du Bois 14:20 – 15:00 HIPEC

• Pro Anna Fagotti • Cons

Jalid Sehouli • Take home message Pierandrea De Iaco 15:00 – 15:10 Discussion

(7)

THURSDAY JUNE 22nd, 2017

Session – Ovarian Cancer – Hot Topics in Medical Treatment Chairmen: Sandro Pignata – Domenica Lorusso – Dionyssios Katsaros 15:10 – 15:25 Beva Maintenance Therapy

In high risk patients or according to the label ? Nicoletta Colombo

15:25 – 16:05 The Parp Inhibitors era:

• For BRCA mutated patients Eric Pujade Lauraine • For all comers

Mirza Raza Mansoor • Take Home Messages Domenica Lorusso

16:05 – 16:35 Treatment of recurrences beyond platinum Sandro Pignata

Treatment algorithm: the changing landscape Isabelle Ray Coquard

16:35 – 16:45 DISCUSSION

17:00 – 17:30

ASSEMBLEA ANNUALE DEI SOCI SIOG

(8)

FRIDAY JUNE 23rd, 2017

Session – Uterine cancer

Chairmen: Tiziano Maggino – Giovanna Salerno Paolo Casali – Paolo Zola (TBC)

8:30 – 8:45 Mini-invasive surgery: focus on feasibility, morbidity and costs

Fabio Ghezzi

8:45 – 9:25 Is sentinel node detection the new standard in nodal status evaluation?

• Pro

Fabio Martinelli • Cons

Fulvio Zullo

• Take home message Alessandro Buda 9:25 – 9:35 Discussion

9:35 – 10:15 High Risk uterine confined endometrial cancer Adjuvant treatment

• RT

Jose Luis Guinot (TBC) • Chemotherapy Ana Oaknin

• Take Home Messages Anna Maria Cerrotta 10:15 – 10:25 Discussion

10:25 –10:40 How could endometrial cancer treatment change in the light of the ongoing trials?

Stefano Greggi

10:40 – 10:55 Update in sarcoma treatment Giovanni Grignani

10:55 –11:25 COFFEE BREAK

(9)

FRIDAY JUNE 23rd, 2017

Session – Cervical cancer

Chairmen: Roberto Angioli –Maria Gabriella Ferrandina –Enrico Vizza 11:25 – 11:40 Role of HPV vaccines in Cervical Cancer

Prevention and treatment Giorgio Bogani

11:40 – 12:25 Treatment in stage IB1 • Conservative options Fabio Landoni

• Non conservative options Francesco Raspagliesi

• Sedlis criteria for adjuvant treatment:

are they still working?

Innocenza Palaia 12:25 – 12:35 Discussion

12:35 – 13:20 Locally advanced Disease role of chemotherapy Roberto Angioli

Is adenocarcinoma really a different entity ? Mauro Signorelli

Perspective in cervical cancer treatment Claudia Marchetti

13:20 – 13:30 Discussion 13:30 – 14:30 LUNCH

14:30 –15:15 KEY LECTURES

Chairmen: Alberto Laffranchi – Giorgio Giorda (TBC) Complementary medicine for the oncologic patient:

Clinical evidence Elio Rossi

Reduction of adverse effects of anticancer therapies and improvement of the quality of life of the oncologic patient Elio Rossi

Nutrition and prognosis in oncologic patients Annalisa Mascheroni

15:15 –15:30 Closing remarks and CME test

(10)

Fondazione IRCCS

Istituto Nazionale dei Tumori Via Venezian 1 – 20133 Milano HOW TO REACH US:

By Subway:

MM2 (Green Line )

• Stop Piola, walking 600 meters

• Stop Lambrate, Bus line 93, stop piazzale Gorini

By Bus:

• Bus line 93 stop piazzale Gorini

• Bus line 61 stop piazzale Gorini By Tram:

• Tram 5 stop in via Amadeo

By Car:

• Tangenziale Est exit viale Forlanini, direction city center to viale Corsica, at the third traffic light turn right in via Lomellina, then straight on via Aselli and piazza Gorini, turn right in via Venezian

By Train:

• Stazione Milano Centrale then Subway MM2

• Stazione Milano Cadorna then Subway MM2

• Stazione Milano Porta Garibaldi then Subway MM2

• Stazione Milano Lambrate then Subway MM2

VENUE

(11)

REGISTRATION FEES

Physicians Euro 300,00 (VAT 22% included)

Nurses and Radiation therapists Euro 150,00 (VAT 22% included) MITO and SIOG members * FREE

Residents ** FREE

*To benefit from membership fees, physicians must indicate in the Registration Form their Scientific Society of affiliation and membership number.

** Residents (under the age of 35) must submit by e-mail or by fax a certificate signed by the head of the De- partment and a copy of a valid ID together with their registration.

Please note that an additional on-site registration fee of Euro 60,00 will be applied For participating is necessary to fill in the registration on

www.advancesgynecologiconcology.org Registration fee includes:

• CME Accreditation

• Access to all Scientific Sessions

• Congress kit and attendance certificate

• Badge

• Final Scientific Program

Cancellation Policy

• 50% of the total fee will be refunded for cancellations received before May 31st 2017

• After the above-mentioned deadlines, no reimbursement can be claimed for cancellation All approved refunds will be processed and issued 90 days after the Congress.

All cancellations concerning the registration fee must be written to secretariat@advan- cesgynecologiconcology.org

DEAD LINE REGISTRATION

Registrations must be receive by June 9th, 2017

GENERAL INFORMATION

(12)

Supported by unrestricted grant of:

GOLD SPONSOR

SILVER SPONSOR

BRONZE SPONSOR

Con il supporto non condizionante di MSD ITALIA S.R.L. www.msd-italia.it Con il supporto non condizionante di MSD ITALIA S.R.L. www.msd-italia.it

Con il supporto non condizionante di MSD ITALIA S.R.L. www.msd-italia.it

VERSIONE PER CONGRESSI CON ECM

CME Provider

and Organizing Secretariat Arseducandi srl

[Standard Provider n. 317]

Viale Gian Galeazzo, 3 20136 Milan (Italy)

Ph. + 39 02 58189248 e-mail:

s[email protected]

Travel Agency PV Agency S.p.A

Viale Gian Galeazzo 3 20136 Milan (Italy) Ph. + 39 02 58189204

e-mail:

[email protected]

Riferimenti

Documenti correlati

President Domenico Andrea Campanacci Honorary President Rodolfo Capanna LOCAL WORKING COMMITTEE Giovanni Beltrami – Treasurer Lorenzo Andreani Simone Colangeli Pierluigi

Al Congresso della European Society for Medical Oncology, AIOM ribadisce che i nuovi medicinali possono far risparmiare il sistema Se è vero che negli ultimi cinque anni, dal 2013

Medical Oncology, Gastro-Entero- Pancreatic and neuroendocrine Unit National Cancer Institute - IRCCS Milan, Italy..

subscription is free after registration online from the website www.mitcongressi.it section: 2 nd riMOG new and emerging Therapeutic Options in Geriatric Oncology..

Associate Professor of General Surgery University of Padua, Medical Surgery Manager Veneto Institute of Oncology Padua (Italy).

Christian Rolfo: Clinical Trial Management Program Oncology Department University Hospital Antwerp UZA, Edegem, Belgium Luca Toschi: Humanitas Cancer Center, IRCCS U.O. di Oncologia

Italian Oncologists Got Talent Breast cancer – multidisciplinary experts and interactive firing squad sessions. Ore 14.00-18.30 Moderator:

Department of Melanoma Medical Oncology - Research, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas.